Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Forest Laboratories

Founders Hans Lowey

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$78M
Portfolio companies 3
Rounds per year 0.04
Lead investments 3
Exits 1
Key employees 1

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Biopharma
  • Medical Device
Summary

Forest Laboratories appeared to be the Corporate Investor, which was created in 1954. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the New York.

The usual cause for the fund is to invest in rounds with 1 partaker. Despite the Forest Laboratories, startups are often financed by Polaris Partners, New Enterprise Associates, HealthCare Ventures.

We can highlight the next thriving fund investment areas, such as Medical Device, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight moksha8 Pharmaceuticals, TransTech Pharma, Trevena. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

This Forest Laboratories works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this Corporate Investor is 80 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2014. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2010.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Forest Laboratories:
Typical Co-investors
Forest Laboratories is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Forest Laboratories:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ALS Society of Canada Canada, Markham, Ontario
Annapurna Pictures California, Los Angeles, United States
BeeLabs -
Bose Ventures Framingham, Massachusetts, United States
Capitaleye Investments Gauteng, Johannesburg, South Africa
Carcharodon Capital Baden-Wurttemberg, Germany, Stuttgart
Cosine New York, New York, United States
DFS Deutsche Flugsicherung Germany, Hessen, Langen
Dry Canyon Holdings Lindon, United States, Utah
Echelon Capital -
Extens Consulting France, Ile-de-France, Paris
Fides Capital Madrid, Madrid, Spain
Focus Holdings -
Funk Ventures California, Pacific Palisades, United States
Infinite Capital California, San Francisco, United States
MANNING & NAPIER Fairport, New York, United States
Meitu China, Fujian, Xiamen
Meriken Nominees -
Oisix Japan, Shinagawa
Spinnaker Capital Partners, LLC Boston, Massachusetts, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Trevena

Biopharma
Biotechnology
Health Care
Pharmaceutical
$60M09 May 2013 Upper Merion Township, Pennsylvania, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Forest Laboratories?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 78M
Rounds per year 0.04
Peak activity year 2013
Lead investments 3
Exits 1

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Trevena

Biopharma
Biotechnology
Health Care
Pharmaceutical
$60M09 May 2013 Upper Merion Township, Pennsylvania, United States
Crunchbase icon

Content report

The following text will be sent to our editors: